Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio Gil-Ortega

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medicina Clinica|December 6, 2006
[Diabetic miocardiopathy]Ignacio Gil-Ortega, Juan Carlos Kaski
Revista Espanola De Cardiologia (English Ed.)|October 29, 2015
Spanish Catheter Ablation Registry. 14th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2014)Ignacio Gil-Ortega, Alonso Pedrote-Martínez, Adolfo Fontenla-Cerezuela, et al.
Revista Espanola De Cardiologia (English Ed.)|May 28, 2018
Response to ECG, May 2018Ignacio Gil-Ortega, Beatriz Garrido-Corro, Juan Antonio Castillo-Moreno
Revista Espanola De Cardiologia (English Ed.)|October 4, 2014
Spanish Catheter Ablation Registry. 13th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2013)Angel Ferrero de Loma-Osorio, Ignacio Gil-Ortega, Alonso Pedrote-Martínez, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitusRamón Ríos-Vázquez, Raquel Marzoa-Rivas, Ignacio Gil-Ortega, et al.
Future Cardiology|October 7, 2009
Role of inflammation and endothelial dysfunction in the pathogenesis of cardiac syndrome XIgnacio Gil-Ortega, Raquel Marzoa Rivas, Ramón Ríos Vázquez, et al.
Revista Espanola De Cardiologia|June 2, 2009
Catheter ablation of focal atrial tachycardia from the non-coronary aortic sinusIgnacio Gil-Ortega, Arcadio García-Alberola, Juan Martínez-Sánchez, et al.
Journal of Cardiology Cases|December 12, 2018
An unique case suffering from repetitive syncope episodes due to ictal asystoleIgnacio Gil-Ortega, Beatriz Garrido-Corro, Milagros Gil-Ortega, et al.
Drugs in Context|October 5, 2020
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocolTeodoro Iturbe-Hernandez, Luis García de Guadiana Romualdo, Ignacio Gil Ortega, et al.
Drugs in Context|February 11, 2022
Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocolJuan José Cerezo-Manchado, Olga Meca Birlanga, Luis García de Guadiana Romualdo, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medicina Clinica|December 6, 2006
[Diabetic miocardiopathy]Ignacio Gil-Ortega, Juan Carlos Kaski
Revista Espanola De Cardiologia (English Ed.)|October 29, 2015
Spanish Catheter Ablation Registry. 14th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2014)Ignacio Gil-Ortega, Alonso Pedrote-Martínez, Adolfo Fontenla-Cerezuela, et al.
Revista Espanola De Cardiologia (English Ed.)|May 28, 2018
Response to ECG, May 2018Ignacio Gil-Ortega, Beatriz Garrido-Corro, Juan Antonio Castillo-Moreno
Revista Espanola De Cardiologia (English Ed.)|October 4, 2014
Spanish Catheter Ablation Registry. 13th Official Report of the Spanish Society of Cardiology Working Group on Electrophysiology and Arrhythmias (2013)Angel Ferrero de Loma-Osorio, Ignacio Gil-Ortega, Alonso Pedrote-Martínez, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
Peroxisome proliferator-activated receptor-gamma agonists for management and prevention of vascular disease in patients with and without diabetes mellitusRamón Ríos-Vázquez, Raquel Marzoa-Rivas, Ignacio Gil-Ortega, et al.
Future Cardiology|October 7, 2009
Role of inflammation and endothelial dysfunction in the pathogenesis of cardiac syndrome XIgnacio Gil-Ortega, Raquel Marzoa Rivas, Ramón Ríos Vázquez, et al.
Revista Espanola De Cardiologia|June 2, 2009
Catheter ablation of focal atrial tachycardia from the non-coronary aortic sinusIgnacio Gil-Ortega, Arcadio García-Alberola, Juan Martínez-Sánchez, et al.
Journal of Cardiology Cases|December 12, 2018
An unique case suffering from repetitive syncope episodes due to ictal asystoleIgnacio Gil-Ortega, Beatriz Garrido-Corro, Milagros Gil-Ortega, et al.
Drugs in Context|October 5, 2020
Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocolTeodoro Iturbe-Hernandez, Luis García de Guadiana Romualdo, Ignacio Gil Ortega, et al.
Drugs in Context|February 11, 2022
Dabigatran in patients with atrial fibrillation after COVID-19 hospitalization: an update of the ANIBAL protocolJuan José Cerezo-Manchado, Olga Meca Birlanga, Luis García de Guadiana Romualdo, et al.
Pageof 2